MedPath

Reduction of harmful alcohol and tobacco use in the general population by individualized e-coach assisted computer or smartphone interventions. Study part 1

Not Applicable
Conditions
hazardous alcohol consumption (women >12 g/d, men > 24g/d)
F10.1
F 17.1
F 17.2
Registration Number
DRKS00007860
Lead Sponsor
niversitätsklinikum Tübingen
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
29
Inclusion Criteria

harmful alcohol consumption (> 12g alcohol/day in women; > 24 g alcohol/day in men or at least one binge-drinking-day/month defined as at least 4 drinks/day in women and at least 5 drinks/day in men);
smoking at least 5 cigarettes per day for the last 4 weeks, smoking duration at least 2 years;
sufficient language capability;
access to the internet at least once per week (PC or smartphone)

Exclusion Criteria

Moderate/Severe Alcohol Use Disorder (DSM 5);
Severe cognitive impairment (clinician's assessment; ICD-10 F0x, F72);
Severe organic disease which enables eligibility (clinician's assessment, e.g. moribund patient);
bipolar disorder or schizophrenia (self report, ICD 10 F2x, F31);
consumption of illicit drugs during the last 5 years (ICD 10 F10, F11-F16, F18, F19);
Treatment utilisation because of alcohol or tobacco use during the last 4 weeks prior to enrolment in the study.

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
tilization and practicability of the developed online/smartphone application by computer-aided qualitative content analysis of research data gained from focus groups (N=30 subjects, 5 interview groups, 5-8 subjects each) 4 weeks after completing treatment of N=40 subjects receiving the newly developed experimental intervention CS-I (no control group).
Secondary Outcome Measures
NameTimeMethod
Alcohol and tocbabbcco use (amount and frequency; Timeline Followback) and motivation to change (Prochaska und DiClemente; Likert-Scale) weekly during receiving the newly developed online-intervention.
© Copyright 2025. All Rights Reserved by MedPath